SCHEMBL20135908

SCHEMBL20135908

Cc1cnc(C=O)c(-c2ncco2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 3/20 0.37
BRD4 O60885 1/20 0.35
HCRTR1 O43613 5/20 0.35
HCRTR2 O43614 4/20 0.35
TUBB4A P04350 2/20 0.32
TUBB P07437 2/20 0.32
TUBA3C P0DPH7 2/20 0.32
TUBA1B P68363 2/20 0.32
TUBA4A P68366 2/20 0.32
TUBB4B P68371 2/20 0.32
TUBB3 Q13509 2/20 0.32
TUBB2A Q13885 2/20 0.32
TUBB8 Q3ZCM7 2/20 0.32
TUBA3E Q6PEY2 2/20 0.32
TUBA1A Q71U36 2/20 0.32
TUBA1C Q9BQE3 2/20 0.32
TUBB6 Q9BUF5 2/20 0.32
TUBB2B Q9BVA1 2/20 0.32
TUBB1 Q9H4B7 2/20 0.32
CFTR P13569 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18471539 0.76 NOS3 (0.46) OPRK1BRD4HCRTR1HCRTR2CFTR
SCHEMBL16031783 0.74 HCRTR1 (0.45) OPRK1BRD4HCRTR1HCRTR2TUBB4A
SCHEMBL20135895 0.73 CCR1 (0.39) OPRK1BRD4HCRTR1KMT2ACCR1
SCHEMBL20135913 0.72 BRD4 (0.38) BRD4HCRTR1HCRTR2HPGDSPIN1
SCHEMBL1289874 0.68 ALDH1A1 (0.42) BRD4TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL1206724 0.68 NOS3 (0.46) KMT2ACCR1CCR5CCR8
SCHEMBL13114685 0.66 HPGDS (0.47) OPRK1BRD4TUBB4ATUBBTUBA3C
SCHEMBL5210212 0.66 KDM4E (0.37) OPRK1BRD4TUBB4ATUBBTUBA3C
SCHEMBL3725066 0.66 BRD4 (0.38) BRD4HCRTR1HCRTR2TUBB4ATUBB
SCHEMBL20278394 0.66 HPGDS (0.33) OPRK1HCRTR1HCRTR2HPGDSKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970207-B1 SUBSTITUTED PIPERIDINE COMPOUNDS AND THEIR USE AS OREXIN RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2018-05-16 EP claimed